Natco Pharma, Celgene ink pact for cancer treatment drug Lenalidomide

Lenalidomide is used to treat various types of cancers.

Published On 2020-07-11 07:17 GMT   |   Update On 2020-07-11 07:17 GMT
Advertisement

New Delhi: Natco Pharma on Friday said its Canadian subsidiary has entered into a settlement agreement with biopharmaceutical firm Celgene (part of Bristol-Myers Squibb) for Lenalidomide capsules.

Lenalidomide is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells.

"Natco Pharma (Canada) Inc., Canada, a subsidiary of Natco Pharma Ltd has entered into a settlement agreement with Celgene (now part of Bristol-Myers Squibb) for the product Lenalidomide Capsules in Canada," the company said in a regulatory filing.

The terms of the agreement are confidential as per the agreement, the company added.

Shares of Natco Pharma were trading 0.15 per cent lower at Rs 676.50 apiece on BSE.

Read also: COVID 19: Natco Pharma supports Columbia University trials for CQ tablets to prevent infections


Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News